Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23398,100,1.12 [0.92-1.36],0.2763921381015865
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24030,181,1.07 [0.92-1.24],0.3902172893925575
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23799,1158,1.05 [0.99-1.12],0.0814426763704107
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Candidiasis,24061,407,1.03 [0.94-1.14],0.5054272044892554
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23312,3043,1.05 [1.01-1.08],0.0136189840391338
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,2472,1.03 [0.99-1.07],0.1388473829517735
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23808,1170,1.07 [1.01-1.13],0.0294454784493628
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23959,80,1.15 [0.92-1.43],0.2299175525042683
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22469,697,1.05 [0.97-1.13],0.2135539591013612
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21706,796,1.05 [0.98-1.13],0.1619756459181755
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21762,217,1.03 [0.90-1.18],0.6337697122603312
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16880,1430,1.05 [1.00-1.11],0.0584074749917283
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21567,318,1.08 [0.97-1.21],0.152113761010502
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23998,1360,1.05 [1.00-1.11],0.0757220027065481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Mycoses,24114,460,1.04 [0.95-1.14],0.3908346974637442
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23462,821,1.04 [0.97-1.11],0.3102319476741509
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24065,767,1.06 [0.98-1.13],0.1399767982495374
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22819,181,1.07 [0.92-1.24],0.3734399032799721
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24170,39,1.04 [0.76-1.43],0.798300489306898
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23975,677,1.04 [0.97-1.13],0.2556433530650285
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23955,76,1.06 [0.85-1.33],0.5973325526816995
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other viral diseases,24085,168,1.13 [0.97-1.31],0.1213207679871732
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24070,153,1.10 [0.94-1.29],0.2230537793483562
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22936,295,1.09 [0.97-1.22],0.1552615482044808
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22866,225,1.07 [0.94-1.22],0.3299538755613327
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22737,99,1.14 [0.94-1.39],0.1926945239868735
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24147,35,1.01 [0.72-1.40],0.9659624170181678
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24102,141,0.92 [0.78-1.09],0.3487878106364912
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral warts,24002,41,0.88 [0.65-1.19],0.4032321858742341
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24031,70,0.92 [0.73-1.17],0.512365091760985
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm,23927,208,1.02 [0.89-1.16],0.8121307971874927
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24077,61,0.96 [0.75-1.23],0.7467202212956172
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24070,59,1.21 [0.94-1.57],0.1468511253002491
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23914,1055,1.00 [0.94-1.07],0.9027042925578048
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of meninges,24145,75,1.18 [0.94-1.49],0.1543685914614326
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24111,61,1.13 [0.88-1.46],0.3362817277460568
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24139,116,1.10 [0.91-1.32],0.3277145151449081
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of ovary,24100,150,1.06 [0.90-1.24],0.4890791286699317
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Ascending colon,24150,237,0.90 [0.80-1.03],0.1226790364698737
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Caecum,24156,215,0.92 [0.81-1.05],0.2214785564336835
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24089,58,0.88 [0.68-1.13],0.3233089892484755
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Descending colon,24154,132,0.83 [0.70-0.98],0.0325963368026273
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Rectum,24117,242,1.01 [0.89-1.14],0.9126329213928946
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24070,439,0.97 [0.89-1.07],0.5735501741124892
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Transverse colon,24155,248,0.98 [0.87-1.11],0.7995997185160233
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Carcinoma in situ of breast,19562,122,0.83 [0.69-0.99],0.0335481689870596
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19633,140,0.90 [0.77-1.07],0.232000373821748
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19628,31,0.85 [0.60-1.21],0.3669063360252046
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19654,57,1.01 [0.78-1.32],0.92068060933889
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24108,126,0.92 [0.78-1.10],0.3662113419502385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma, any site",24109,124,0.92 [0.77-1.10],0.3575081044713989
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Leiomyoma of uterus,23285,505,0.97 [0.89-1.05],0.4490151144201975
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Lung cancer and mesothelioma,17363,282,0.90 [0.80-1.01],0.0873118394659601
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Lymphoid leukaemia,19632,35,0.88 [0.63-1.22],0.4434023770528636
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19753,156,1.05 [0.90-1.23],0.5290070107163789
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19693,96,0.97 [0.79-1.18],0.7477689852335427
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19765,168,0.93 [0.80-1.08],0.3300757842972535
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19658,61,1.11 [0.86-1.43],0.4163125040739481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19656,59,1.02 [0.79-1.32],0.870971254119545
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19644,47,1.04 [0.78-1.39],0.7869001571348767
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19727,130,1.09 [0.91-1.29],0.3558296169746267
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19689,92,1.10 [0.90-1.36],0.3554018857459881
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19672,75,1.01 [0.80-1.27],0.9304719982136068
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19633,36,1.21 [0.87-1.69],0.2528288215965765
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19668,71,0.83 [0.66-1.05],0.1137120433048459
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi,23936,209,1.13 [0.99-1.30],0.0741835498644865
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi of trunk,24129,70,1.16 [0.92-1.47],0.2211014698511425
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanoma in situ,19626,77,1.18 [0.94-1.49],0.1461195963550916
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19669,72,1.04 [0.82-1.31],0.7649064855294907
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19732,135,1.11 [0.94-1.32],0.2244049976457155
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19803,206,0.86 [0.74-0.98],0.0263272544332745
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19681,84,1.24 [1.00-1.55],0.0527552800445549
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Other benign neoplasms of skin,23971,156,1.00 [0.85-1.16],0.9546900826265624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20412,815,0.97 [0.90-1.04],0.3637678023410359
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20448,851,0.98 [0.91-1.05],0.4946075335974956
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23886,340,0.96 [0.87-1.07],0.4828140831551166
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22427,85,0.91 [0.73-1.13],0.3818058485909454
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23616,70,1.05 [0.83-1.33],0.680454277431506
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23276,2582,1.06 [1.02-1.10],0.0021755400666899
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22755,27,1.11 [0.76-1.63],0.5835388219875621
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23818,43,1.33 [0.98-1.80],0.067296584983629
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23654,1312,1.06 [1.01-1.12],0.0236451173388046
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23654,1312,1.06 [1.01-1.12],0.0236451173388046
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22409,67,1.07 [0.84-1.36],0.5982508229185095
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23807,1079,1.15 [1.08-1.22],7.851176479561459e-06
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23878,103,0.86 [0.71-1.05],0.1308836021742219
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23592,46,1.06 [0.79-1.43],0.6785124290158127
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23600,54,1.08 [0.83-1.41],0.5696903649824263
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23982,207,1.02 [0.89-1.17],0.7916638184662919
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24075,54,1.30 [0.99-1.70],0.0593781159252984
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23951,176,0.87 [0.75-1.00],0.0559830648002121
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22842,114,1.24 [1.03-1.49],0.0229917136385584
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19503,211,0.96 [0.84-1.10],0.5474999548698299
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,59,1.00 [0.77-1.29],0.978755332037505
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22914,55,1.20 [0.92-1.57],0.1719699457114592
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19335,43,1.25 [0.92-1.70],0.1488077371084469
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22167,54,0.98 [0.75-1.28],0.8950056328284746
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21887,209,0.98 [0.86-1.13],0.8113752200985359
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23783,423,0.93 [0.85-1.03],0.1486488086895253
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23624,264,0.97 [0.86-1.10],0.6761384606411498
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23421,61,1.08 [0.84-1.39],0.5594418949010898
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23830,1717,1.04 [0.99-1.09],0.1442208904375154
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21437,1679,1.04 [0.99-1.09],0.1004925279613922
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19339,47,1.34 [1.00-1.80],0.0507606286776888
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21495,103,1.03 [0.84-1.25],0.8034525289132799
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19539,247,1.05 [0.93-1.19],0.4364909605063493
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19335,43,1.26 [0.93-1.72],0.1322321787243945
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22040,2748,1.07 [1.03-1.11],0.000782245274998
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19477,185,1.00 [0.86-1.15],0.9647859481921996
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19769,477,1.05 [0.96-1.15],0.2711009457433244
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24084,314,1.14 [1.02-1.27],0.0218440715827062
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23916,146,1.20 [1.02-1.42],0.0274259573807788
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19381,89,1.00 [0.81-1.24],0.9801157419921984
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19342,50,1.12 [0.84-1.48],0.445141758263024
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23399,2007,1.04 [1.00-1.09],0.0645824497140383
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19469,177,0.98 [0.84-1.13],0.7518892823921179
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19466,174,1.10 [0.94-1.28],0.2266313785602503
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19760,468,1.05 [0.96-1.15],0.2878900312534288
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19363,71,1.05 [0.83-1.34],0.6623088859852675
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23910,140,1.17 [0.99-1.38],0.0669513744212847
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19828,536,0.98 [0.90-1.06],0.5671213565871861
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19778,486,1.04 [0.95-1.14],0.4059187997254402
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,64,1.10 [0.86-1.41],0.431758362517657
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23397,4105,1.05 [1.02-1.08],0.0013983089084796
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21456,64,0.91 [0.72-1.17],0.4686433646097009
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21468,76,1.05 [0.83-1.31],0.7001916201753385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24005,1797,1.00 [0.96-1.05],0.9632843972325036
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24009,1796,1.00 [0.96-1.05],0.9535554181496076
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21466,74,1.09 [0.86-1.37],0.4747859529912158
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23806,1383,1.05 [0.99-1.10],0.0964736813347122
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20598,1306,1.02 [0.97-1.08],0.4817206126175537
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24160,160,1.03 [0.88-1.20],0.734092130580821
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23402,42,1.08 [0.79-1.46],0.628550297454626
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22544,121,1.00 [0.83-1.19],0.9821600100268216
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22594,171,1.09 [0.94-1.27],0.2658771660292935
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19512,220,1.19 [1.04-1.36],0.0124089418771167
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22566,122,1.08 [0.90-1.29],0.4158907390447194
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1497,38,0.92 [0.67-1.27],0.6170178450680361
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1592,150,1.07 [0.91-1.25],0.4253373990229996
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22469,25,1.56 [1.04-2.36],0.032528969945725
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1480,22,0.84 [0.56-1.26],0.4005401282299511
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23753,1309,1.08 [1.02-1.14],0.0055271739499561
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23656,296,0.96 [0.85-1.08],0.4755192888995598
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22098,420,1.00 [0.91-1.10],0.949721511509548
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19914,622,1.04 [0.96-1.13],0.2885012866514432
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24081,206,0.85 [0.74-0.97],0.0172784950912166
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23269,44,0.98 [0.73-1.31],0.8808134890446412
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Angina pectoris,22831,761,1.07 [0.99-1.15],0.075417647779094
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Aortic aneurysm,23305,80,0.92 [0.74-1.14],0.4533734153296848
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23254,29,1.17 [0.81-1.68],0.4102732608650147
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23364,139,0.98 [0.83-1.15],0.7693651545474446
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15700,1270,1.02 [0.97-1.08],0.412448429047541
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,AV-block,21204,213,1.06 [0.92-1.21],0.4208730616338112
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24128,264,0.91 [0.81-1.03],0.1262739681140633
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Cardiac arrest,14539,109,1.17 [0.97-1.42],0.09994628159512
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21111,120,0.84 [0.70-1.00],0.0543842792885354
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21064,73,1.06 [0.84-1.33],0.6302323789338076
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24166,28,0.94 [0.65-1.35],0.7311972752719996
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Conduction disorders,21628,637,1.05 [0.97-1.14],0.1981796501293018
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23369,1310,1.06 [1.00-1.12],0.0343480009111109
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21757,6411,1.04 [1.01-1.06],0.0029751880598288
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22855,219,0.90 [0.79-1.03],0.1351601351903578
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Endocarditis,21038,47,1.02 [0.76-1.36],0.9111855986298564
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Heart failure, strict",24082,731,1.09 [1.02-1.18],0.0168248067720394
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertension,22306,5398,1.04 [1.01-1.06],0.0121349229846843
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, essential",22314,5406,1.03 [1.01-1.06],0.0126174502035325
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, portal",24069,35,0.67 [0.49-0.93],0.0178226067868151
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17061,153,1.02 [0.87-1.19],0.8244402672419961
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16976,68,1.11 [0.87-1.42],0.3840727504691343
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypotension,24050,928,0.96 [0.90-1.02],0.2175207600088722
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23508,85,1.00 [0.81-1.24],0.9706814537426086
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23552,1482,1.07 [1.01-1.12],0.0138986960941775
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23894,398,1.02 [0.93-1.13],0.6603932844232017
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Left bundle-branch block,21261,270,1.02 [0.90-1.15],0.7500647341745388
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23979,532,1.06 [0.98-1.16],0.1611899877083769
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22495,425,1.11 [1.01-1.22],0.0381623081645861
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24146,78,1.34 [1.07-1.67],0.0118881990187353
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24162,211,1.10 [0.96-1.26],0.1801386282076122
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Oesophageal varices,22670,34,0.77 [0.55-1.07],0.1195159193666051
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other aneurysm,23275,50,0.85 [0.64-1.12],0.2459072162674897
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other arrhythmias,21313,322,1.08 [0.97-1.21],0.1503830280187034
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23285,60,1.26 [0.97-1.63],0.0777083805199933
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23399,174,0.95 [0.82-1.11],0.5287933243856467
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21138,147,0.89 [0.76-1.04],0.1538627346624549
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other disorders of veins,22712,76,1.02 [0.82-1.28],0.8447948390298421
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22678,42,1.12 [0.83-1.52],0.4573130324311755
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23076,32,0.85 [0.60-1.20],0.353514626628409
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22774,138,1.01 [0.86-1.20],0.888337622653631
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21670,679,1.03 [0.96-1.11],0.4342946464068458
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23160,38,0.81 [0.59-1.10],0.1759655737288586
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,449,0.94 [0.86-1.03],0.1773558641852768
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23654,288,1.01 [0.90-1.14],0.8483415331500728
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23513,469,0.98 [0.89-1.07],0.6445108952670675
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14681,251,1.06 [0.93-1.20],0.3754828696846881
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23460,246,0.94 [0.83-1.06],0.3097320468760567
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22924,288,0.95 [0.85-1.07],0.4062403124069486
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23756,390,1.05 [0.95-1.16],0.3140731189906176
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24097,504,1.00 [0.91-1.09],0.9118550255042256
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Right bundle-branch block,21176,185,1.09 [0.94-1.26],0.2505218053994085
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23647,281,1.02 [0.91-1.15],0.7076084899562187
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23179,135,0.90 [0.76-1.07],0.2419392195929791
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23885,462,1.01 [0.92-1.11],0.7830459086649368
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23861,503,1.01 [0.92-1.10],0.8651797705889709
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23477,62,1.01 [0.79-1.29],0.9340716721496712
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23262,37,1.12 [0.80-1.55],0.5156165988331438
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23682,186,1.13 [0.98-1.30],0.1020152502134833
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23625,178,1.04 [0.89-1.20],0.6421748074628718
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Varicose veins,23019,383,0.98 [0.88-1.08],0.6533273049494583
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23234,83,0.92 [0.74-1.14],0.4640822311023624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23981,615,1.01 [0.93-1.09],0.7990299571068987
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24131,196,1.05 [0.91-1.21],0.487041928930772
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21483,1617,1.05 [1.00-1.10],0.0519880096884727
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Any mental disorder,23644,3778,1.03 [1.00-1.06],0.0814931799737453
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24105,232,1.03 [0.90-1.17],0.6733478079582041
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21601,1735,1.04 [0.99-1.09],0.0909111238348902
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19945,79,1.09 [0.87-1.36],0.4709704913086484
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Smoking dependency,23817,1043,1.04 [0.98-1.11],0.2216035724635904
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21076,1210,1.03 [0.98-1.09],0.2391639102656295
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Vascular dementia,23739,93,0.97 [0.79-1.19],0.7819539311450687
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Alzheimer disease,24168,327,0.97 [0.87-1.08],0.5699858247087777
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16568,53,1.06 [0.81-1.41],0.6619376936677781
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Bell's palsy,22288,71,0.96 [0.76-1.21],0.7274808189900901
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22779,562,1.01 [0.93-1.09],0.8685651992450987
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Cerebral cysts,23817,190,1.06 [0.92-1.23],0.397939005976589
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24103,237,0.93 [0.82-1.06],0.2841405351187658
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23742,39,0.99 [0.73-1.36],0.9697891584001096
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24157,44,1.41 [1.04-1.90],0.0261037846093124
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23672,45,0.97 [0.72-1.30],0.8195737934385915
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Epilepsy,22886,249,0.94 [0.83-1.07],0.3355161459002611
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23800,1163,1.02 [0.96-1.08],0.4918148990009863
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24124,310,1.06 [0.94-1.18],0.3437430213298376
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Falls/tendency to fall,23624,2541,0.96 [0.93-1.00],0.0698433731114058
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Generalized epilepsy,23847,42,1.24 [0.91-1.68],0.1653982064351228
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Hemiplegia,24055,189,0.97 [0.85-1.12],0.7271304323243916
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Hydrocephalus,23682,55,1.10 [0.84-1.43],0.4825248203440991
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24150,65,1.23 [0.97-1.58],0.0936846625951381
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22330,113,0.91 [0.76-1.10],0.3380329760025264
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22272,55,1.18 [0.91-1.54],0.2202962331889604
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Memory loss,23625,93,1.10 [0.90-1.35],0.3654401070156778
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Migraine,23085,448,1.05 [0.96-1.16],0.2727026742071242
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24066,406,1.05 [0.95-1.16],0.3220147945643539
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Motor neuron disease,16657,117,0.92 [0.76-1.10],0.3480566293915085
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23965,124,1.01 [0.85-1.20],0.9091370396422944
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23439,1222,1.01 [0.96-1.07],0.6970571601886064
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Neurological diseases,22746,3250,1.01 [0.97-1.04],0.7175395938507385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23828,125,0.97 [0.81-1.15],0.7168325317506141
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22586,369,1.06 [0.95-1.17],0.2998689959946085
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24115,196,1.04 [0.91-1.20],0.5635135181826201
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19558,583,0.97 [0.89-1.05],0.4653657396185376
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23686,59,1.04 [0.81-1.34],0.7641659886405763
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other disorders of nervous system,23737,110,0.87 [0.73-1.05],0.1468461693523684
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23958,144,1.08 [0.91-1.27],0.3791915211775947
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other facial nerve disorders,22296,79,0.96 [0.77-1.20],0.745447817127287
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other headache syndromes,22705,68,1.20 [0.94-1.53],0.1357096717044497
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other neurological diseases,24065,438,1.03 [0.94-1.13],0.5403475922201362
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other sleep disorders,22985,348,0.97 [0.88-1.08],0.6002582856845444
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Parkinson's disease,24145,145,1.01 [0.86-1.19],0.8753090194483021
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23699,72,1.19 [0.94-1.51],0.15125990099931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Restless leg syndrome,24167,77,0.99 [0.79-1.23],0.908902250781056
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Sleep apnoea,24013,278,0.97 [0.86-1.09],0.5731746183095185
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Small fibre neuropathy,23953,34,1.22 [0.87-1.71],0.2510741672326425
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24158,142,0.85 [0.72-1.00],0.0549641157412758
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22279,62,1.00 [0.78-1.29],0.972271262525184
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24168,330,0.97 [0.87-1.09],0.6294577223197608
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23698,90,0.97 [0.79-1.20],0.7931271945745916
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23650,94,0.97 [0.80-1.19],0.8011160212049053
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23760,427,0.98 [0.89-1.07],0.6284084089596563
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24042,143,1.08 [0.91-1.27],0.3875239630419477
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,53,1.06 [0.81-1.39],0.6842873557920398
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23185,49,1.19 [0.90-1.58],0.2306658604824462
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24058,57,1.29 [0.99-1.68],0.0583319416338428
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23918,148,0.97 [0.82-1.14],0.7154856232289288
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1486,27,0.98 [0.67-1.42],0.8986298859425195
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1780,55,0.88 [0.67-1.15],0.3485507512641209
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23641,85,0.92 [0.75-1.14],0.4603527137419646
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24015,925,1.07 [1.00-1.14],0.0358968024446155
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23789,653,1.00 [0.93-1.08],0.9444428656530598
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23399,263,1.03 [0.91-1.16],0.6249795332631771
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24092,759,1.00 [0.93-1.08],0.9701648087482628
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24156,64,1.10 [0.86-1.41],0.450138096977419
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24023,690,1.00 [0.93-1.08],0.9847389020685092
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24129,359,0.95 [0.86-1.05],0.331602519530993
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24083,185,0.95 [0.82-1.10],0.4818460988140107
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23173,37,1.03 [0.74-1.43],0.8598036047602219
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23176,40,1.20 [0.87-1.64],0.2619423839343114
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23197,61,1.08 [0.84-1.39],0.5692207452032054
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24088,630,1.00 [0.93-1.08],0.9809778789599
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23613,155,0.93 [0.80-1.09],0.3990705553647875
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23391,58,1.01 [0.78-1.31],0.9321790336550596
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23859,89,0.93 [0.75-1.14],0.4751218234997505
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24049,279,0.95 [0.85-1.07],0.4242339629146475
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23520,187,0.99 [0.86-1.14],0.8934223989029797
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24018,120,0.92 [0.77-1.10],0.3839231869633073
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23867,409,1.00 [0.91-1.10],0.9786430721336052
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23693,137,1.00 [0.85-1.19],0.966825497129854
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22585,2239,1.04 [1.00-1.08],0.068096038013213
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24015,245,0.97 [0.85-1.10],0.6205733782810972
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24146,141,1.03 [0.88-1.22],0.6906863104809193
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23471,335,1.02 [0.92-1.14],0.7222479890064752
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23829,59,0.87 [0.67-1.12],0.2683852762067706
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24142,50,1.16 [0.88-1.54],0.2990129967414754
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23220,84,0.94 [0.76-1.17],0.5926092651566444
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23263,127,1.00 [0.84-1.19],0.9781769746006664
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23184,94,1.11 [0.91-1.37],0.2995765155141784
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23392,59,0.99 [0.76-1.27],0.9197839400618087
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23148,58,0.83 [0.64-1.07],0.1414117313507827
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23564,106,0.98 [0.81-1.18],0.8198806728619825
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23617,159,0.99 [0.85-1.16],0.8914241060911814
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23248,112,1.06 [0.88-1.28],0.5090005551255593
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23171,81,1.19 [0.95-1.48],0.123858015284332
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23151,61,1.08 [0.84-1.39],0.5582402244331384
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22186,1840,0.99 [0.95-1.04],0.8068399775062982
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23215,79,1.12 [0.89-1.39],0.3347539918571349
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23937,381,0.99 [0.89-1.09],0.7803423783248076
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23597,41,0.85 [0.63-1.15],0.2951324217362724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23705,149,1.17 [0.99-1.38],0.0577340113114841
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23942,102,0.83 [0.68-1.00],0.0511346448120846
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24126,95,0.93 [0.76-1.14],0.5021144172712612
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24059,129,0.98 [0.82-1.16],0.8169907918717266
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23904,64,1.03 [0.81-1.32],0.8070204278157631
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23907,67,0.99 [0.78-1.26],0.9228721943571904
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24073,711,1.01 [0.94-1.09],0.8135145457626456
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23849,487,1.05 [0.96-1.15],0.2693242103930977
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23464,102,0.90 [0.74-1.09],0.2657418764284575
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23438,76,1.13 [0.90-1.42],0.29572338668902
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Acute pharyngitis,23920,75,0.84 [0.67-1.05],0.1167248685039639
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24056,211,0.91 [0.79-1.04],0.1555336464408022
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23902,57,1.01 [0.78-1.31],0.920319252474823
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,All influenza,22682,114,1.01 [0.84-1.21],0.9489434160159688
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22681,113,1.02 [0.84-1.22],0.8642227411839472
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Allergic asthma (mode),17195,114,1.10 [0.91-1.32],0.3289180349843041
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Allergic rhinitis,24043,247,1.11 [0.98-1.26],0.0987307834822852
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18764,1844,1.06 [1.01-1.11],0.0192045260297992
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18900,1819,1.06 [1.01-1.11],0.0178372899220399
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23807,114,1.00 [0.83-1.20],0.9953315836386094
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22628,60,1.06 [0.82-1.37],0.6588255917336578
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Bronchiectasis,20876,348,1.19 [1.07-1.32],0.0014252869324917
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20587,59,1.11 [0.85-1.43],0.4440935992597108
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23153,2625,1.05 [1.01-1.09],0.0088521635751907
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23048,59,0.93 [0.72-1.20],0.57853441237653
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic sinusitis,23118,129,1.19 [1.00-1.41],0.0536770440477478
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24017,908,1.04 [0.97-1.11],0.2785712138822421
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Deviated nasal septum,23056,67,1.06 [0.83-1.35],0.6282372258132223
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22327,4530,1.05 [1.02-1.08],0.000456821151571
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23285,296,1.03 [0.92-1.16],0.5693415129796877
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Early onset COPD,23392,283,1.04 [0.92-1.17],0.5624984614234921
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Emphysema,20761,233,1.23 [1.08-1.40],0.0015609296848861
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22685,203,0.98 [0.85-1.12],0.7774582315221369
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23992,1424,1.02 [0.97-1.08],0.4396111140049779
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Interstitial lung disease,22720,238,0.98 [0.86-1.11],0.7485846522475077
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Later onset COPD,23354,625,1.05 [0.97-1.13],0.2659734386942395
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24162,193,1.00 [0.87-1.15],0.9893559739178416
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Nasal polyp,23047,58,1.02 [0.79-1.32],0.885621794058863
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23967,819,1.01 [0.94-1.08],0.8740128132356516
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of pleura,24003,1534,1.05 [1.00-1.10],0.0769184582061131
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23677,688,1.11 [1.03-1.20],0.0063176900057869
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other pleural conditions,22504,35,0.82 [0.59-1.14],0.2439864336695844
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24093,302,0.97 [0.86-1.08],0.5638588485039144
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24089,1040,1.06 [0.99-1.12],0.074983857207291
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pleural effusion,23199,730,1.05 [0.98-1.13],0.183981701119839
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pleural plaque,22512,43,1.16 [0.85-1.57],0.3430412948242766
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23777,1209,1.02 [0.96-1.08],0.4930130372738122
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24135,166,0.98 [0.84-1.14],0.7998479664787432
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pneumothorax,22558,89,1.05 [0.85-1.29],0.6661852874856338
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pollen allergy,24144,208,1.08 [0.94-1.24],0.2710844019268575
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pulmonary oedema,23845,54,0.86 [0.66-1.12],0.2658563552571766
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Respiratory insufficiency,17125,44,1.32 [0.97-1.78],0.0733511641280193
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23948,800,1.00 [0.93-1.07],0.946164688798512
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23236,247,1.11 [0.98-1.26],0.0909585492055796
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Viral pneumonia,22752,184,1.06 [0.92-1.23],0.3994167844337609
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23815,145,1.03 [0.88-1.22],0.6933366113546069
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11637,90,1.11 [0.90-1.37],0.338273142344133
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17306,35,1.11 [0.80-1.55],0.5323992775662822
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute appendicitis,24001,123,0.82 [0.69-0.98],0.0256482735938652
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute gastritis,18166,75,0.96 [0.77-1.20],0.7231505695763163
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute pancreatitis,22162,143,1.17 [0.99-1.37],0.0694811665854378
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute peritonitis,23662,75,1.23 [0.98-1.55],0.0709740862134719
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Alcoholic liver disease,23413,31,0.92 [0.64-1.30],0.6247556062969206
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Barrett oesophagus,18398,307,1.06 [0.95-1.19],0.2982370353195085
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22089,70,1.21 [0.95-1.53],0.1161715279755236
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23796,70,1.21 [0.95-1.53],0.124312744536287
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholecystitis,22174,155,1.00 [0.85-1.17],0.9823332735837564
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholelithiasis,23070,1051,1.01 [0.95-1.07],0.7572831115102153
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Chronic gastritis,18389,298,1.11 [0.99-1.24],0.0804334126471756
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Chronic pancreatitis,22054,35,0.98 [0.70-1.36],0.8995074013310129
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24097,63,0.84 [0.66-1.07],0.1541398214811598
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Coeliac disease,22817,127,1.08 [0.90-1.28],0.4070941722908937
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Collagenous colitis,22499,95,0.96 [0.79-1.18],0.721626868121342
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24044,140,1.04 [0.88-1.23],0.614245084239418
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Constipation,23868,1484,1.01 [0.96-1.07],0.6408720673905469
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn disease,22478,74,1.10 [0.87-1.38],0.4152940932372416
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23849,52,1.10 [0.84-1.45],0.4871387944453926
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22480,76,1.06 [0.85-1.33],0.6179653325585233
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Dental caries,23433,204,0.99 [0.86-1.13],0.8398230927405584
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22728,2154,1.01 [0.97-1.05],0.6110104216526753
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of appendix,24038,160,0.91 [0.78-1.06],0.2462984059762952
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of liver,24083,701,1.05 [0.98-1.13],0.1884287627836313
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22145,4054,1.01 [0.98-1.05],0.3822759597351032
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23750,521,1.04 [0.95-1.13],0.4034060091214402
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of peritoneum,24057,470,1.09 [1.00-1.19],0.0613745063185648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23335,106,0.90 [0.75-1.09],0.2919465372953667
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of salivary glands,23201,58,1.03 [0.80-1.34],0.8176019621995306
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23910,1220,1.01 [0.95-1.07],0.7354150208596699
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of tongue,23206,90,1.05 [0.85-1.29],0.6599942414017206
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23418,1399,1.03 [0.98-1.09],0.2334053614554706
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20074,2803,1.03 [0.99-1.06],0.1908533237018485
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Duodenal ulcer,18211,120,1.06 [0.89-1.27],0.5075999244614021
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24119,100,1.03 [0.85-1.26],0.7527933756450761
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24079,55,1.35 [1.04-1.76],0.0257822368343727
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23463,81,0.95 [0.76-1.18],0.6243104596465197
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17374,103,1.12 [0.92-1.36],0.2568830569679175
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Functional dyspepsia,18681,590,1.04 [0.96-1.13],0.3422117757095821
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastric ulcer,18396,305,0.98 [0.88-1.10],0.7362441928872454
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20539,2448,1.01 [0.98-1.06],0.4706744315864434
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18511,420,1.01 [0.92-1.11],0.8623240305969211
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18907,7398,1.02 [1.00-1.04],0.0875890827394097
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,GI-bleeding,23664,974,1.00 [0.94-1.06],0.9127663139695164
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23290,61,1.13 [0.88-1.46],0.3421001917384511
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18115,1102,1.06 [1.00-1.13],0.049326266267777
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23416,34,0.82 [0.58-1.14],0.2283639432005688
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Hernia,23114,2540,1.00 [0.96-1.04],0.9028398282698716
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Impacted teeth,24088,51,1.45 [1.10-1.91],0.0091287018706307
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Impaction of intestines,17331,60,1.19 [0.92-1.54],0.1755700946241086
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Inguinal hernia,20723,149,0.94 [0.80-1.10],0.4417405854757492
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17356,85,0.93 [0.75-1.15],0.5166663633475209
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22843,153,1.04 [0.89-1.22],0.6351329671121317
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17984,713,1.03 [0.95-1.10],0.4826684291963791
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24159,303,1.17 [1.05-1.31],0.0064096310465855
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23129,725,1.10 [1.02-1.18],0.0098944789741319
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23372,968,1.10 [1.03-1.17],0.0048934478561031
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophageal obstruction,18226,135,1.20 [1.01-1.43],0.0338459280608582
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophagitis,18597,506,1.03 [0.94-1.12],0.5440357021204578
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24126,142,1.08 [0.92-1.28],0.3345079332589861
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20625,51,1.05 [0.79-1.38],0.7397105103193453
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18369,1098,1.01 [0.95-1.07],0.8590748162405598
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22278,259,1.04 [0.92-1.17],0.5421128769074537
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22184,165,0.96 [0.83-1.12],0.6213618658524458
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestine,18652,1381,0.99 [0.94-1.05],0.7878685000802762
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestines,22258,4987,1.01 [0.98-1.04],0.5544142825390375
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23204,205,1.03 [0.90-1.19],0.6255713348388362
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of liver,23966,584,1.04 [0.96-1.13],0.3151707317995265
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18616,525,1.01 [0.93-1.10],0.7985748755988318
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of pancreas,22156,137,0.95 [0.80-1.13],0.5593856839334819
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23999,412,1.07 [0.97-1.17],0.198469487110604
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19039,948,0.99 [0.93-1.06],0.7532864653904662
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23681,991,1.00 [0.94-1.07],0.9795369768845312
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23385,156,1.03 [0.88-1.20],0.7383487469279446
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18807,1536,1.02 [0.97-1.07],0.4385027758879973
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19936,1845,0.98 [0.94-1.03],0.4839539722527554
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23470,88,0.97 [0.79-1.20],0.8083946534437956
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23259,855,1.08 [1.01-1.16],0.0206822403838539
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17565,294,0.99 [0.88-1.11],0.8395282171069444
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24069,64,1.32 [1.03-1.69],0.0266423459793906
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17708,437,0.96 [0.87-1.05],0.3972158645158938
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22813,123,1.02 [0.86-1.22],0.78833211296341
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Recurring oral aphthae,24160,65,0.96 [0.75-1.22],0.7363671282983187
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23231,118,0.99 [0.82-1.18],0.8860229439788798
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Toxic colitis,22459,55,1.06 [0.81-1.38],0.6767563390557224
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18303,212,1.13 [0.99-1.30],0.0753894950478036
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcerative colitis,22554,150,1.21 [1.03-1.43],0.0186598695509606
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22530,126,1.22 [1.02-1.45],0.0268643089498001
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Umbilical hernia,20729,155,0.84 [0.72-0.98],0.0283712053110188
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17440,169,1.01 [0.87-1.17],0.9157241578941234
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ventral hernia,20793,219,1.00 [0.88-1.14],0.9975562709272222
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Volvulus,17346,75,0.95 [0.76-1.19],0.6737852768362864
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24092,219,1.13 [0.99-1.30],0.0682771534877391
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23883,76,0.87 [0.70-1.09],0.2207713118671074
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22368,198,1.04 [0.91-1.20],0.5678982611777337
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23689,550,1.01 [0.93-1.09],0.8864754960578269
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23271,132,1.00 [0.85-1.19],0.9620740884808902
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22450,280,0.93 [0.83-1.05],0.2328568415785583
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23888,250,1.06 [0.94-1.20],0.364834983053649
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24066,428,1.01 [0.92-1.11],0.8236625310653212
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23683,45,0.93 [0.69-1.24],0.6136917005401425
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22764,2790,1.00 [0.97-1.04],0.8983854296300722
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23774,414,0.93 [0.85-1.03],0.1658400576059807
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23644,284,0.97 [0.86-1.08],0.5476052231106312
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23880,741,0.99 [0.92-1.07],0.8603418960696336
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24149,68,1.05 [0.83-1.33],0.6853365870600674
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22257,87,0.84 [0.68-1.04],0.1034491858676993
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23401,41,1.13 [0.83-1.53],0.4470607646122735
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23874,236,1.04 [0.92-1.19],0.5063537845943895
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22537,367,1.05 [0.95-1.17],0.3212271142434938
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22217,47,0.97 [0.73-1.28],0.808217596805675
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24076,70,0.88 [0.70-1.11],0.2685523567113103
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23272,133,1.07 [0.90-1.27],0.4245295268965829
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23960,153,0.76 [0.65-0.89],0.0007476981752764
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23681,43,1.05 [0.78-1.42],0.7527135655992798
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22228,58,1.02 [0.79-1.31],0.9003579233552823
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23574,1404,1.01 [0.96-1.06],0.6992742834742987
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22567,397,1.06 [0.96-1.17],0.2760331879341834
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22220,50,0.97 [0.73-1.28],0.8229433911395565
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24093,286,0.86 [0.77-0.97],0.0125362037590417
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23712,74,0.85 [0.68-1.07],0.1640941030433861
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24028,221,0.82 [0.72-0.94],0.0031263273465525
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24120,247,1.12 [0.98-1.27],0.0888869730723824
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22314,144,1.08 [0.92-1.28],0.3377084245349338
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22402,232,1.00 [0.88-1.14],0.9714595790444212
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24108,235,1.11 [0.97-1.26],0.122608746097425
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22346,176,1.08 [0.93-1.26],0.2845405425559648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24135,129,0.92 [0.78-1.09],0.3491440766512199
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20622,117,1.02 [0.85-1.23],0.8112217306495286
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21948,5626,1.00 [0.97-1.03],0.9423748929181072
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20730,4408,1.01 [0.98-1.04],0.5823432869235752
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20572,67,0.92 [0.73-1.17],0.5067144233862895
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20743,132,1.04 [0.88-1.24],0.6148887126308464
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20795,184,1.06 [0.92-1.23],0.4118446327837921
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23915,102,0.82 [0.67-0.99],0.039077598102059
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20714,103,1.01 [0.83-1.23],0.928424716817314
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17541,1219,1.00 [0.94-1.06],0.945476064729567
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24030,200,1.07 [0.93-1.23],0.364140494218197
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21125,514,1.04 [0.95-1.14],0.3696426003148655
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20304,7176,1.00 [0.98-1.03],0.7116207689349094
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21636,122,1.03 [0.86-1.23],0.7469779456046617
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20626,121,1.14 [0.95-1.36],0.1624612368955291
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21117,612,1.02 [0.94-1.11],0.6032424180612882
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23265,2654,1.02 [0.99-1.06],0.2170174080369958
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20664,159,1.07 [0.91-1.25],0.4199232292103094
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20847,342,1.13 [1.02-1.26],0.0248267909470985
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20661,156,1.18 [1.00-1.38],0.0447909814564352
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23296,96,0.93 [0.76-1.14],0.4849927530702257
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17982,1660,1.01 [0.96-1.06],0.6675204581702758
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16504,182,1.10 [0.95-1.28],0.1863496167618626
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24155,179,1.06 [0.92-1.23],0.4187831601711865
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16415,93,1.04 [0.85-1.28],0.6876120554933148
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16837,515,0.93 [0.85-1.01],0.0882372089357318
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20801,296,0.92 [0.82-1.02],0.1246635503066872
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16882,560,1.01 [0.93-1.09],0.8962493659754485
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20670,59,1.15 [0.88-1.49],0.3016377704250947
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21241,630,1.09 [1.01-1.18],0.0356301914891491
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20903,292,1.04 [0.93-1.17],0.4903194641302413
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16841,519,1.01 [0.93-1.10],0.844841018989339
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20581,76,1.27 [1.01-1.59],0.0422866848601241
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20565,60,1.06 [0.82-1.36],0.6610919851104394
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21557,43,1.14 [0.84-1.55],0.3847972167625864
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23746,2232,0.99 [0.95-1.03],0.586252809069323
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23122,1608,0.99 [0.95-1.04],0.7675782945640414
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23983,522,1.04 [0.96-1.14],0.3209391554353957
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19017,2695,1.01 [0.97-1.05],0.595878684009626
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16384,62,0.92 [0.72-1.18],0.5174716073954172
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20596,91,1.18 [0.96-1.45],0.1130903190035113
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16364,42,0.98 [0.72-1.33],0.9010293450950456
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16504,182,1.02 [0.88-1.18],0.7952985649602873
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21777,263,0.96 [0.85-1.08],0.487124026423075
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22018,504,0.95 [0.87-1.04],0.2401517405530724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24144,95,1.12 [0.91-1.37],0.2785673643445226
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22400,1789,1.05 [1.00-1.10],0.0545308774458447
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20618,113,0.89 [0.74-1.06],0.1985571459186995
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16532,210,0.91 [0.79-1.04],0.1651706096271493
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21323,712,1.02 [0.95-1.10],0.5192663750805857
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18575,2253,1.00 [0.96-1.04],0.8653279258722132
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23316,116,0.95 [0.79-1.14],0.5711992704336057
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24150,75,0.94 [0.75-1.18],0.5835128907432101
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20570,65,1.18 [0.92-1.50],0.195436362563567
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21806,1301,1.05 [1.00-1.11],0.0710565418303063
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20578,73,1.20 [0.95-1.51],0.1233653348147239
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18082,1760,1.05 [1.00-1.10],0.031252257744578
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21644,130,1.04 [0.87-1.23],0.6977702722967932
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20555,50,0.95 [0.72-1.25],0.7036371877798713
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20786,175,0.96 [0.83-1.11],0.585298886376354
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21013,508,1.01 [0.93-1.11],0.7376528826405594
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23656,456,1.11 [1.01-1.22],0.0260618347096509
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21180,569,1.02 [0.94-1.10],0.7039864976747165
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23995,505,1.06 [0.97-1.15],0.2278176253519269
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24142,58,1.18 [0.91-1.53],0.2061558244176879
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20703,198,0.95 [0.82-1.09],0.4388098265351325
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18535,805,1.03 [0.96-1.11],0.3711274333323259
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21093,588,1.02 [0.94-1.10],0.7050681102891605
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20614,109,1.15 [0.95-1.38],0.1580178272200488
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16395,73,0.98 [0.78-1.23],0.864846462350706
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18656,2334,1.04 [1.00-1.09],0.0441822197514758
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17061,739,1.02 [0.95-1.10],0.6184753023546268
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23462,262,1.10 [0.97-1.24],0.1267300178106254
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24119,70,0.99 [0.78-1.25],0.916890320541341
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22139,48,1.10 [0.83-1.46],0.5004084098384358
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16398,76,0.92 [0.74-1.16],0.4927886366918101
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20710,99,1.02 [0.84-1.25],0.8281717090918991
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16848,526,1.04 [0.96-1.14],0.3504439694354423
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20791,286,0.90 [0.80-1.01],0.0725759801630012
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20864,253,1.09 [0.97-1.24],0.1576806871981015
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20854,243,1.04 [0.92-1.18],0.5184569331363531
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18635,75,1.23 [0.98-1.55],0.0744030406302372
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24148,64,1.05 [0.82-1.34],0.699398471539755
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21066,561,0.96 [0.89-1.05],0.3845213001608175
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23349,149,1.09 [0.93-1.28],0.2989586987612986
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22995,2490,1.03 [0.99-1.07],0.1455542633434007
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20643,138,0.89 [0.75-1.05],0.1700750724732669
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21100,489,1.06 [0.97-1.16],0.1879264279041753
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22618,229,0.96 [0.85-1.10],0.5747914259466336
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20828,217,1.03 [0.90-1.17],0.7033173214281643
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22135,1524,0.99 [0.94-1.04],0.7480651967632186
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21645,1034,0.99 [0.93-1.05],0.7942442051857694
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20561,56,1.08 [0.83-1.41],0.5574871191419624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23415,215,0.92 [0.80-1.05],0.2174453365332104
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20684,179,1.01 [0.87-1.17],0.8766089554540616
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20621,116,0.92 [0.77-1.10],0.3529473368768275
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16367,45,1.17 [0.87-1.57],0.3074224598911302
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Acute renal failure,23316,1050,1.05 [0.99-1.12],0.1124599999453841
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18086,88,1.10 [0.89-1.36],0.3632213533415547
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23557,99,0.95 [0.78-1.16],0.6015010788600477
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24027,203,1.12 [0.98-1.29],0.0991002127316089
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23847,23,0.70 [0.47-1.05],0.0863565338312598
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23437,1171,1.01 [0.95-1.07],0.8038193951341501
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24027,58,0.78 [0.60-1.00],0.0530124976809538
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23994,203,0.96 [0.84-1.10],0.5883760687598163
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Cystitis,21348,222,0.95 [0.83-1.09],0.4615834648170894
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Dialysis,22312,46,1.27 [0.95-1.70],0.1107274390057953
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23745,287,0.99 [0.88-1.11],0.8915670133597867
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Endometriosis,18150,152,1.02 [0.87-1.20],0.7883299167606256
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18342,344,0.90 [0.81-1.00],0.0601748730947794
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18877,879,1.05 [0.98-1.12],0.146954868390473
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18787,4355,1.01 [0.98-1.04],0.499862171153436
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24021,52,0.96 [0.73-1.25],0.7506549196259351
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22144,182,0.96 [0.83-1.11],0.6165920284018716
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23683,352,1.00 [0.90-1.11],0.9313574438102866
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Irregular menses,23757,111,0.76 [0.63-0.91],0.0031345080386893
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,269,1.03 [0.91-1.16],0.685189476529171
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21193,67,1.10 [0.86-1.40],0.4421697344298868
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20140,2142,0.99 [0.95-1.03],0.6532081536247574
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18117,119,1.08 [0.90-1.29],0.3980156411573015
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24159,57,1.08 [0.83-1.41],0.5685169426718202
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24159,71,0.91 [0.72-1.14],0.4123570501746579
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23069,1943,1.01 [0.97-1.06],0.538481396878334
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21538,412,0.98 [0.89-1.08],0.6625960627722327
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23560,102,1.00 [0.83-1.22],0.9662397024997724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24116,325,1.05 [0.94-1.17],0.3700238737817243
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24115,77,0.98 [0.78-1.22],0.8264580295158073
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22791,1665,1.03 [0.98-1.08],0.3019286614382931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23513,182,1.06 [0.92-1.23],0.4337426582596707
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18135,137,1.22 [1.03-1.44],0.0236046096854871
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18340,342,1.04 [0.94-1.16],0.4335036361570217
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18101,103,1.08 [0.89-1.31],0.4598901618653543
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18180,182,1.06 [0.91-1.22],0.4688479133870868
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22190,228,0.99 [0.87-1.13],0.9302426563014352
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23899,108,1.17 [0.97-1.42],0.1088906298497196
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18266,268,1.03 [0.91-1.16],0.6683281465005697
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18089,91,1.00 [0.81-1.22],0.9708428715733398
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18561,563,1.01 [0.93-1.10],0.7934797013690282
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18139,141,1.10 [0.94-1.30],0.239429540609911
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18512,514,1.00 [0.91-1.09],0.9509111100389692
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24002,33,0.91 [0.65-1.28],0.5839691789266418
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24014,2052,1.03 [0.98-1.07],0.247724850945011
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22109,147,1.08 [0.91-1.26],0.3792731199208832
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22349,83,1.02 [0.83-1.27],0.8252402374448099
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23855,31,0.90 [0.63-1.27],0.5475104413352894
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urethral stricture,21255,129,1.09 [0.92-1.30],0.3046783318018377
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urolithiasis,24057,233,1.08 [0.95-1.22],0.2685441504066931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Uterine polyps,18117,119,1.07 [0.90-1.28],0.4409703360462661
